Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

544.52
+2.830.52%
Post-market: 545.801.28+0.24%18:48 EDT
Volume:1.20M
Turnover:651.14M
Market Cap:138.15B
PE:31.69
High:546.84
Open:535.38
Low:532.23
Close:541.69
52wk High:555.69
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.46
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.82
PE(LYR):35.54

Loading ...

Vertex Inc. Earnings Call Shows Profitable Growth

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05

Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Fresenius Medical Care (FMS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 04

Movement Alert|Vertex Pharmaceuticals Rises 3.05% in Regular Trading, Q2 Revenue Beats Estimates and Full-Year Guidance Raised

Market Focus
·
Aug 04

Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold

TIPRANKS
·
Aug 04

Vertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth

TIPRANKS
·
Aug 04

Vertex: Buy Rating Reaffirmed Amid Near-Term Demand Headwinds and Strategic Transformation, Price Target Maintained at $20

TIPRANKS
·
Aug 04

Vertex Analysts Lower Their Forecasts Following Q2 Results

Benzinga Earnings
·
Aug 04

Vertex Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $605 from $600

THOMSON REUTERS
·
Aug 04

Press Release: Vertex Expands Leadership Team to Power the Next Chapter of Growth

Dow Jones
·
Aug 04

Vertex is Maintained at Outperform by Baird

Dow Jones
·
Aug 04

Vertex price target lowered to $17 from $19 at Baird

TIPRANKS
·
Aug 04

Cantor Fitzgerald Adjusts PT on Vertex Pharmaceuticals to $595 From $590, Maintains Overweight Rating

MT Newswires Live
·
Aug 04

Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $550 from $525

THOMSON REUTERS
·
Aug 04

Analysts’ Top Technology Picks: Vertex (VERX), Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX)

TIPRANKS
·
Aug 04

Vertex Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 04

Vertex Q2 2026 earnings: Cloud growth lifts adjusted EBITDA margin to 25%

TradingKey
·
Aug 04